logo
Select company
Select metric
$ -257.49MEarning Before Interest & Taxes (EBIT)
VS
Market
4
Sector
6
Industry
8
History
14
$ 12.96Close
$ 2.29 - $ 18.94 52-Week Range
Ticker Information

Ticker

PHAT

Company Name

PHATHOM PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PHATHOM PHARMACEUTICALS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PHAT - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -257.49M
3/31/2025$ -272.88M
12/31/2024$ -262.32M
9/30/2024$ -273M
6/30/2024$ -239.04M
3/31/2024$ -196.71M
12/31/2023$ -159.62M
9/30/2023$ -138.53M
6/30/2023$ -147.21M
3/31/2023$ -161.11M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PHATHOM PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT stands at $ -169.03M.
  • Over the past 5 years, PHATHOM PHARMACEUTICALS INC's average EBIT has been $ -180.45M.
  • The median EBIT for PHATHOM PHARMACEUTICALS INC during this period was $ -158.82M
  • PHATHOM PHARMACEUTICALS INC reached its highest EBIT over the past 5 years at $ -124.49M.
  • The lowest EBIT recorded by PHATHOM PHARMACEUTICALS INC in the same timeframe $ -273M

PHATHOM PHARMACEUTICALS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
GYRE : GYRE THERAPEUTICS INC $ 7MANAB : ANAPTYSBIO INC $ -132.52MNAGE : NIAGEN BIOSCIENCE INC $ 18.33MCRMD : CORMEDIX INC $ 51.72MTBPH : THERAVANCE BIOPHARMA INC $ 42.66MZYME : ZYMEWORKS INC $ -67.42MURGN : UROGEN PHARMA LTD $ -136.01MZVRA : ZEVRA THERAPEUTICS INC $ 29.88MXNCR : XENCOR INC $ -134.76MKURA : KURA ONCOLOGY INC $ -193.34M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

PHAT - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -273M

Minimum

Sep 30, 2024

$ -124.49M

Maximum

Dec 31, 2020

$ -180.45M

Average

$ -158.82M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.62M with a standard deviation of $ 130.62M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.62M
median$ 897.02K
std$ 130.62M